Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 5401-5410 Newer>

The Motley Fool January 30, 2009 Brian Orelli	Good Luck in 2010, Zimmer Medical device maker Zimmer met analysts expectations in the fourth quarter, but investors weren't impressed with the company's guidance.
The Motley Fool January 30, 2009 Brian Orelli	The Health Benefits of Obama's IT Obsession Digital health records are on their way. Which companies are ready to benefit from this new technology?
Reason	Shopping for fertility markets Reproduction rules vary by country. For example, in France, gamete donation, sperm insemination, and in vitro fertilization (IVF) are available only to married couples or common-law spouses.
The Motley Fool January 29, 2009 Brian Orelli	Lilly's in Need of a Pep Pill Eli Lilly's quarterly earnings report was pretty boring. Some drugs were up and others were down -- the end result was flat sales.
The Motley Fool January 29, 2009 Brian Orelli	No Buyer's Remorse at Boston Scientific The pacemakers and defibrillators that Guidant contributed to Boston Scientific's bottom line are still growing strong, but the company had to take a whopping $2.7 billion goodwill writedown because the value of what it purchased has changed.
The Motley Fool January 29, 2009 Brian Orelli	A Secondary Offering? In This Market? For these pharma companies, when the value of their company drops even though they haven't had any bad news, the secondary-offering step becomes very costly for current shareholders.
The Motley Fool January 29, 2009 Brian Orelli	Novartis: Diversification Isn't Good Enough Novartis has become a better diversified company, with acquisitions of vaccines specialist Chiron and 25% of eye-care specialist Alcon, but it's far from a cure all, as the fourth quarter showed.
The Motley Fool January 28, 2009 Brian Orelli	M&A Off the Beaten Path CV Theraputics gets courted.
The Motley Fool January 28, 2009 Brian Orelli	The Streak Is Over After 31 consecutive quarters of double-digit sales growth, medical device maker Stryker finally had an off quarter.
The Motley Fool January 28, 2009 Brian Orelli	Worth Every Penny People still need to take their antiviral medication even if the purse strings are tight, and that fact has led Gilead Sciences to putting together another great quarter.
<Older 5401-5410 Newer> Return to current articles.